A Phase-3 multi centre, randomized, parallel, double blind, placebo control, clinical study to determine the efficacy and safety of Betadine Nasal spray Povidone Iodine IP 0.5% w/v for the treatment of Rhinitis in patients suffering from Rhinitis associated with Upper respiratory tract infection along with standard care of therapy. - NIL
100 Clinical Results associated with G.S. Pharmbutor Pvt Ltd.
0 Patents (Medical) associated with G.S. Pharmbutor Pvt Ltd.
100 Deals associated with G.S. Pharmbutor Pvt Ltd.
100 Translational Medicine associated with G.S. Pharmbutor Pvt Ltd.